⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
HCWB News
HCW Biologics Inc. Common Stock
HCW Biologics Maintains Momentum Toward Completion of IND Application for Clinical Study to Evaluate Lead T-Cell Engager in Solid Tumors
globenewswire.com
HCWB
Form 8-K
sec.gov
HCWB
HCW Biologics Announces Pricing of $1.5 Million Private Placement
globenewswire.com
HCWB
Form 8-K
sec.gov
HCWB
Form 8-K
sec.gov
HCWB
HCW Biologics Entered an Exclusive Distribution Agreement with Akron Biotech to Commercialize HCW11-006 as Reagent Used to Support Production of Highly Functional Human CAR-T Cells
globenewswire.com
HCWB
HCW Biologics Strengthens U.S. Patent Estate for Its Lead Clinical-Stage Immunotherapeutic HCW9302 as Alopecia Areata Treatment
globenewswire.com
HCWB
HCW Biologics’ TGF-β Trap and IL-15 Fusion is a Novel Moiety to Enhance Immunotherapeutic Activity against Diseased Cells
globenewswire.com
HCWB
Form 8-K
sec.gov
HCWB
HCW Biologics Reports Second Quarter 2026 Business and Clinical Development Highlights and Financial Results
globenewswire.com
HCWB